Mr John Feneley (Chair), Professor Alan Rosen, Ms Judith Mackson, Prof Andrew McLachlan, Ms Kerin O’Halloran, Dr Titia Sprague, Ms Sam Stott, Dr Michael Tam, A / Prof Timothy Wand, Dr Murray Wright
A / Prof Timothy Chen, Mr Carlton Quartly
Ms Erin O'Loughlin
Ms Danielle Keogh
1. Welcome and apologies
The Commissioner welcomed members. The apologies of A/Prof Tim Chen and Mr Carlton Quartly were accepted.
2. Minutes from previous meeting
The minutes of the meeting held 8 October 2015 were accepted.
3. Commissioner update
The Commissioner advised the group that the One Year on Report, on the implementation of Living Well: A strategic plan for metal health in NSW, was submitted to the NSW Minister for Mental Health, The Hon. Pru Goward. In February the Minister tabled the report in parliament.
One year on focuses on the preparations agencies have made to better support the people of NSW by strengthening community based responses to mental health needs and to shift our system from acute crises towards prevention and earlier intervention.
4. Medication and mental illness paper and film
Erin O’Loughlin, Communications Advisor, NSW Mental Health Commission, presented to the group the communications plan for the medication paper and film that has been active since the 2 December 2015 launch.
Highlights include: stories in Psychiatry Update, Australian Doctor, 6Minutes, and potential use of the depression film by NPS in treating depression in general practice campaign.
The group shared their individual efforts to distribute the paper and film amongst colleagues and networks. For example Sam Stott told the group that the paper is now used in the South Eastern Sydney Recovery College medication course.
The group agreed that the paper and films were a good resource and that the messages within should be exploited further.
5. Opportunities for the Commission to leverage change
The group discussed ways the Commission could use the medication paper and films to promote change. The group agreed that the Commission should consider developing a ‘postcard’ with the paper’s key messages, that consumers can hand to their clinicians to start a conversation about the quality use of medicines in their treatment. The Commission will test this idea with a group of consumers.
6. Any other business
The group discussed pharmacogenomics. Discussion included that the results from pharmacogenmoic testing can be useful. The tests may influence decision-making about type of medication, dose and frequency of administration. However it was also noted that these tests should not solely be relied on for decision making about medicines. Other factors that should influence decision making include the person’s goals, the person’s lived experience of medications, complexity of medication regimes, and costs of medication.
7. Next meeting
Monday, 12 September 2016, 4pm – 6pm, NSW Mental Health Commission, Gladesville.